Origin Life Sciences, Inc. (OLSI)

Origin Life Sciences will go public soon, but the exact IPO date is still unknown.

IPO Price

$4.00

Shares Offered

1,875,000

Deal Size

$7.50M

Origin Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	79	-	-
Enterprise Value	81	-	-
Debt / Equity Ratio	-0.14	-0.14	-0.08
Debt / EBITDA Ratio	-0.31	-0.31	-0.21
Debt / FCF Ratio	-1.98	-1.98	-1.42
Quick Ratio	0.05	0.05	0.00
Interest Coverage	-77.25	-77.25	-125.34
Return on Equity (ROE)	44.67%	44.67%	37.59%
Return on Assets (ROA)	-507.99%	-507.99%	-621.91%
Return on Capital (ROIC)	17.68%	17.68%	41.72%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).